American College of Rheumatology Releases Updated Guidelines …
Jun 18, 2021 · The American College of Rheumatology (ACR) recently released updated guidelines for the pharmacologic management of rheumatoid arthritis (RA). The full report has been published simultaneously in Arthritis Care & Research and Arthritis & Rheumatology.. Overall, the updated guidelines include treatment with disease-modifying antirheumatic drugs (DMARDs), including biologic DMARDs (bDMARDs) and ...
Facet Hypertrophy | Diagnosis & Disease Information
Sep 12, 2022 · Etiology and Risk Factors. Spondylosis, or degeneration of the spine, is the most common cause of facet joint disease. Osteoarthritis, or degeneration that is due to natural wear and tear, is a process that involves cytokines and proteolytic enzymes. Other causes of facet hypertrophy can include trauma caused by car accidents, sports injuries, or falls. 1
2022 ACR/AAHKS Guidelines for Management of
Apr 6, 2022 · References. American College of Rheumatology & American Association of Hip and Knee Surgeons. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty: guideline summary.
FDA Roundup: Rheumatology Drug Alerts 2024
Mar 5, 2024 · Throughout 2024, the United States Food and Drug Administration (FDA) approved new drugs for the treatment of osteoporosis, rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), giant cell arteritis, Duchenne muscular dystrophy (DMD), and certain cancers, while also expanding treatment indications for previously approved drugs.
Leukocytoclastic Vasculitis - Rheumatology Advisor
Aug 4, 2022 · Diagnostic Workup. The diagnostic workup for leukocytoclastic vasculitis does not follow a uniform series of steps. If the skin biopsy indicates a diagnosis of leukocytoclastic vasculitis, the goal is to determine whether there is systemic involvement and …
Hydroxyapatite Crystal Deposition Disease (HADD)
Nov 15, 2022 · History and Epidemiology. A typically uniarticular condition, hydroxyapatite (HA) crystal deposition disease (HADD) is marked by the presence of hydroxyapatite crystals in the periarticular soft tissues, especially the tendons 1.HA is a mineral found in normal bone, but when it builds up in and around the joints it can cause inflammation, tenderness, and pain.
Drug-Induced Lupus | Diagnosis & Disease Information
Aug 4, 2022 · Epidemiology. Drug-induced lupus occurs in people who take certain types of medication but it is not considered a drug side effect. 1, 2 Flare ups caused by medications taken for pre-existing or latent lupus are excluded from this diagnosis. 1 With drug-induced lupus, specific drugs trigger an autoimmune reaction and the production of autoantibodies. 3 There are three types of drug-induced ...
Rheumatology ICD 10 Codes
May 10, 2023 · This is a comprehensive table of rheumatology ICD 10 codes used by researchers as well as healthcare professionals and personnel—nurses, medical coders, physicians, et al.
Undifferentiated Connective Tissue Disease - Rheumatology Advisor
Aug 9, 2022 · Undifferentiated connective tissue disease (UCTD) is a diagnosis of exclusion. Patients who present with clinical and serolotical manifestations that suggest a systemic autoimmune disease but do not fulfill criteria for defined connective tissue disease (eg, systemic lupus erythematosus, scleroderma, myositis, rheumatoid arthritis, Sjogren's syndrome) are classified to have UCTD.
Roflumilast Foam Under Review for Scalp, Body Psoriasis
Sep 27, 2024 · References: FDA accepts Arcutis’ supplemental new drug application for Zoryve ® (roflumilast) foam for the treatment of scalp and body psoriasis in adults and adolescents ages 12 and over. News release. Arcutis Biotherapeutics, Inc. Accessed September 24, 2024.